Adam is responsible for the research of current and next-generation probiotics and building a strong portfolio of scientific data to support Chr.Hansen’s commercial probiotic business. Focusing on the key role of bacteria throughout life and how these bacteria play key roles in our health, in particular the interactions between the bacteria and the host microbiome at a molecular and clinically functional level. Prior to Chr. Hansen Adam worked as the VP of Diagnostic Product Develop at Exiqon A/S in Denmark for 5 years and as the Head of New Technologies in deCODE Genetics in Iceland.